Your browser doesn't support javascript.
loading
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.
Arulanandam, Rozanne; Taha, Zaid; Garcia, Vanessa; Selman, Mohammed; Chen, Andrew; Varette, Oliver; Jirovec, Anna; Sutherland, Keara; Macdonald, Elizabeth; Tzelepis, Fanny; Birdi, Harsimrat; Alluqmani, Nouf; Landry, Anne; Bergeron, Anabel; Vanderhyden, Barbara; Diallo, Jean-Simon.
Afiliação
  • Arulanandam R; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Taha Z; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Garcia V; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
  • Selman M; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Chen A; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
  • Varette O; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Jirovec A; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Sutherland K; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Macdonald E; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Tzelepis F; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
  • Birdi H; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Alluqmani N; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
  • Landry A; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Bergeron A; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
  • Vanderhyden B; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
  • Diallo JS; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Commun Biol ; 3(1): 254, 2020 05 22.
Article em En | MEDLINE | ID: mdl-32444806
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rhabdoviridae / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Sinergismo Farmacológico / Terapia Viral Oncolítica Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rhabdoviridae / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Sinergismo Farmacológico / Terapia Viral Oncolítica Idioma: En Ano de publicação: 2020 Tipo de documento: Article